Connecting Sign in

Insider trades appear within seconds, the rest within the hour.

Get alerts

← Feed

SRPTNasdaq · Pharmaceutical Preparations

Sarepta Therapeutics, Inc.

Alert me on SRPT
0
Insider buys, 6 months
0
Congress trades, 6 months
0
Signals, 6 months

Six months

After each filing

3
Mar 14 Sale Mayo Stephen Insider
1 week
+6.3%S&P −1.8%
1 month
+30.4%S&P +4.9%
3 months
−5.3%S&P +13.1%
6 months
+24.4%S&P +13.8%
Dec 19, 2025 Sale Estepan Ian Michael Insider
1 week
+3.7%S&P +1.1%
1 month
+3.6%S&P +1.2%
3 months
−16.3%S&P −3.8%
6 months
−20.7%S&P +8.3%
May 6, 2025 Sale Rep. Gilbert Cisneros House
1 week
−2.7%S&P +4.7%
1 month
+17.1%S&P +6.8%
3 months
−51.1%S&P +13.0%
6 months
−49.2%S&P +21.4%

Every purchase and sale on this ticker reported by a member of Congress or an insider, measured from the close of the first trading day after it became public to the close 1 week, 1 month, 3 months and 6 months later, each beside the S&P over the same days.

Filings for SRPT

56 held · newest 556 held · newest 2
Loading the filings.
See all 56 filings for SRPT

Aeon news and offers by email

New sources, new features and offers like our founding price. A few times a month at most. Stop any time.

Government contracts, last 12 months

Awards of $10M and up, from USAspending · context, not a signal
No contracts of $10M or more in the last 12 months.

Lobbying

Last four quarters
$230KQ4 2025
$270KQ1 2026
$220KQ2 2026
$160KQ3 2026
Down 27 percent from Q2 2026. Reported by the company to the Senate each quarter.Original report ↗

Read from LDA.gov between Sep 23, 2026 and Oct 21, 2026. Senate Office of Public Records cannot vouch for the data or analyses derived from these data after the data have been retrieved from LDA.gov.